Search clinical trials for: NAFLD, Diabetes, Glitazone

Total 77 results

Cairo University

Not yet recruiting

Isokinetic Strength and Balance Assessment in Diabetic Patients

Diabetes

Egypt
Dokuz Eylul University
Necmettin Erbakan University

Recruiting

The Effect of Mobile Application Robot Developed for Pediatric Diabetes Management on Children With Diabetes Mellitus (DM)

Adolescent | Diabetes Mellitus, Type 1 | Children

Turkey
Dokuz Eylul University

Recruiting

The Effect of Mobile Application on the Pediatric Diabetes Management (DM)

Adolescent | Diabetes Mellitus, Type 1 | Child

Turkey
Oslo University Hospital
Vestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaborators

Recruiting

Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose (DIASA3)

Glucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin Sensitivity

Norway
Andrea Giaccari

Recruiting

Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity (DapaHeart)

Type2 Diabetes Mellitus | Stable Coronary Artery Disease

Italy
Insel Gruppe AG, University Hospital Bern
University of Zurich; Cantonal Hospital of St. Gallen

Recruiting

Swiss Diabetes Registry - SwissDiab Study (SwissDiab)

Diabetes Mellitus

Switzerland
Ruhr University of Bochum

Terminated

Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment

Diabetic Foot

Germany
Kırklareli University

Completed

The Effects of Video Training Given to Individuals With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Training

Turkey
Uşak University

Completed

Gingival Crevicular IL-34 and CSF-1 Levels in Patients With Periodontitis and Uncontrolled Type 2 Diabetes

Diabetes | Periodontitis

Turkey
University Hospital, Gentofte, Copenhagen

Completed

The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes (GA-16)

Type2 Diabetes

Denmark
University Hospital, Montpellier

Completed

DiaPort Closed-Loop Artificial Pancreas

Type 1 Diabetes Mellitus

France
Shire

Terminated

A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension

Hypotension, Orthostatic

United States
Riphah International University

Completed

Aerobic And Strength Training Exercises For Restless Leg Syndrome In Patients With Diabetes

Diabetes | Restless Legs Syndrome

Pakistan
Samaritan Health Services

Completed

GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study (GOTCHA)

Coronavirus Infection | Diabetes

United States
University of Leipzig
Heart Center Leipzig - University Hospital

Terminated

Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery Disease (KFO)

Obesity | Impaired Glucose Tolerance | Severe Coronary Artery Disease

Germany
Hospital General Puyo

Unknown

Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group

Type1diabetes | Childhood ALL

Argentina
Mount Sinai Hospital, Canada
Canadian Institutes of Health Research (CIHR)

Completed

Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial) (RESET-IT)

Type 2 Diabetes

Canada
Novartis

Completed

A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

Hypertension | Diabetes

Switzerland, Sweden, Romania, Belgium, Spain, United States, Ukraine
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Sleep Apnea in Type 1 Diabetes (DIASOM)

Type 1 Diabetes, Sleep Apnea Syndrome

France
Imperial College London
GlaxoSmithKline

Withdrawn

Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study

Diabetes Mellitus, Type 2

United Kingdom
Novartis Pharmaceuticals

Terminated

Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes (VIDA)

Type 2 Diabetes Mellitus

Mexico
AstraZeneca

Completed

Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

Type 2 Diabetes Mellitus | Inadequate Glycaemic Control

Germany, Slovakia, Czechia, Hungary, Poland
University of Hawaii
Kaiser Permanente; RTI International; Centers for Medicare and Medicaid Services and other collaborators

Completed

Hawaii Patient Reward And Incentives to Support Empowerment (HI-PRAISE)

Diabetes Mellitus

United States
AstraZeneca

Completed

Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian Patients (FOREFRONT)

Type 2 Diabetes

India
AstraZeneca

Completed

A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes

Type 2 Diabetes Mellitus | Inadequate Glycaemic Control

United States, Canada, Czechia, Germany, Russian Federation, Mexico
Royal Devon and Exeter NHS Foundation Trust
King's College London; King's College Hospital NHS Trust; Newcastle University; Newcastle-upon-Tyne Hospitals NHS Trust and other collaborators

Completed

PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes (PROMASTER)

Diabetes

United Kingdom
Unidad de Investigacion Medica en Enfermedades...

Unknown

Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy (CURCUNRF2)

Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Polymorphism

Mexico
Assistance Publique - Hôpitaux de Paris

Completed

Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes (INDAO)

Diabetes | Gestational

France
GlaxoSmithKline

Completed

A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

United States
GlaxoSmithKline

Completed

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Diabetes Mellitus, Type 2

Argentina, Germany, United States
Abbott Diabetes Care

Completed

An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes (REPLACE)

Type 2 Diabetes Mellitus

France, United Kingdom, Germany
University of California, Davis

Completed

Assessment of an Intervention to Prevent Obesity and Diabetes in Latino Farm Workers (Pasos)

Overweight and Obesity

United States
Abbott Diabetes Care

Completed

An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT) (IMPACT)

Type 1 Diabetes Mellitus

Austria, Netherlands, Germany, Spain, Sweden
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

Type 2 Diabetes

United States
National Institute of Allergy and Infectious Diseases...
GlaxoSmithKline

Completed

Rosiglitazone Effect on Mitochondria and Lipoatrophy

HIV Infections

United States
Massachusetts General Hospital

Terminated

Ultrasound Method to Measure Fibrosis of the Liver in Children

HBV | Chronic Liver Disease | HCV Coinfection | Non-Alcoholic Fatty Liver Disease | Drug-Induced Liver Injury

United States
French National Agency for Research on AIDS and...

Terminated

Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance (PEGLIST C)

Insulin Resistance | Chronic Hepatitis C

France
GlaxoSmithKline

Completed

Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

Diabetes Mellitus, Type 2

United States, Dominican Republic, Chile
Abbott Diabetes Care

Completed

Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes (SIGN)

Diabetes Mellitus

United Kingdom
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients

Type 2 Diabetes Mellitus (T2DM)

Japan
Novartis Pharmaceuticals

Completed

Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients

Non-alcoholic Fatty Liver Disease (NAFLD)

United States
The University of Texas Health Science Center at...

Completed

Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes (PIO-TACE)

Type 2 Diabetes

United States
Nazarbayev University
Institute Of Cardiology & Internal Diseases, Kazakhstan

Completed

Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome (DRWMNTMS)

Metabolic Syndrome

Kazakhstan
Samsung Medical Center

Completed

The Effect of Online Based Mentoring Program on the Blood Glucose and Satisfaction Score in Type 1 Diabetes Patients

Type 1 Diabetes

Korea, Republic of
University Hospital, Montpellier

Completed

Hybrid Artificial Pancreas in Home Setting (AP Hybrid)

Type 1 Diabetes Mellitus | Treatement by Insulin Pump

France, Netherlands, Italy
Emory University
GlaxoSmithKline

Completed

Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes

Hypertension | Type 2 Diabetes

United States
University of Leipzig

Completed

Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease (KFO)

Obesity | Impaired Glucose Tolerance | Stable Coronary Artery Disease

Germany
University of Primorska
University of Ljubljana School of Medicine, Slovenia

Completed

E-health Care Process Support for Diabetes Type II Patients (EHDI)

Diabetes Mellitus Type II,

Slovenia
AstraZeneca
Juvenile Diabetes Research Foundation

Completed

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Type 1 Diabetes

United States
Command Hospital, India

Unknown

A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease (GLAZED)

Fatty Liver

India

Search clinical trials for: NAFLD, Diabetes, Glitazone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations